Manmeet Ahluwalia, Chief Scientific Officer at the Miami Cancer Institute, shared a post by Ahmad Ozair on X/Twitter, adding:
”Congratulations Ahmad Ozair for the prestigious Rosenblum-Mahaley award! Glad to see our translational work from The Adult Brain Tumor Consortium trial recognized.”
Quoting Ahmad Ozair’s post:
”High-grade glioma session CNS, CNS2023, CNS23 has started. Come see Manmeet Ahluwalia & our work on translational findings from RNA sequencing of patients with recurrent GBM glioblastoma! Grateful to have NS Tumor Section recognize it with the Rosenblum-Mahaley award.”
Source: Manmeet Ahluwalia/Twitter and Ahmad Ozair/Twitter